Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
As of 2026-04-02, BioCryst Pharmaceuticals Inc. (BCRX) trades at a current price of $9.02, marking a 3.84% decline in recent trading sessions. This analysis examines key technical levels, prevailing market context for the biotech sector, and potential near-term scenarios for the stock, without making any investment recommendations. No recent earnings data is available for BCRX as of the current date, so market participants are largely relying on technical signals, sector trends, and potential up
What’s the outlook for BioCryst (BCRX) Stock this year | Price at $9.02, Down 3.84% - Debt Free Stocks
BCRX - Stock Analysis
4073 Comments
544 Likes
1
Camreigh
Returning User
2 hours ago
Ah, if only I had caught this before. 😔
👍 31
Reply
2
Sonye
Trusted Reader
5 hours ago
I understood nothing but I’m thinking hard.
👍 98
Reply
3
Marlus
Legendary User
1 day ago
Missed it completely… sigh.
👍 86
Reply
4
Ynez
Consistent User
1 day ago
Really missed out… oof. 😅
👍 151
Reply
5
Dakaden
Returning User
2 days ago
All-around impressive effort.
👍 277
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.